• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number 9-ASD-012
Medical Device Problem Code Migration or Expulsion of Device (1395)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/29/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2024, a 12mm amplatzer septal occluder was chosen for a 6mm atrial septal defect (asd) using a 8f amplatzer trevisio intravascular delivery system.The device was successfully implanted.Less than five minutes after the procedure, it was noticed that the device was embolized and moved towards the aorta.The physician mentioned the cause of embolization was the anatomy of patient.The device was removed via transcatheter snare.The physician noted that there was a relatively small asd accompanied by a patent foramen ovale (pfo) and there was insufficient edges, so it was decided to send the patient to surgery for closure.There was no clinically significant delay in procedure.The patient was reported discharged.
 
Additional Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of device embolization was reported.The device was returned to abbott for investigation and the device met dimensional specifications when analyzed.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the available information, the cause of the reported device embolization could not be conclusively determined; however, patient¿s condition likely contributed to the reported embolization (small atrial septal defect of 6 mm, accompanied by patent foramen ovale (pfo) and insufficient edge).The reported unexpected medical intervention was a result of case-specific circumstances as the device was removed via transcatheter snare.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19569849
Report Number2135147-2024-02894
Device Sequence Number6948761
Product Code MLV
UDI-Device Identifier00811806010090
UDI-Public(01)00811806010090(17)271231(10)8846369
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number9-ASD-012
Device Lot Number8846369
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/29/2024
Supplement Date Received by Manufacturer08/07/2024
Initial Report FDA Received Date06/19/2024
Supplement Report FDA Received Date08/13/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/18/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age62 YR
Patient SexMale
Patient Weight64 KG
-
-